D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 45 Citations 9,256 104 World Ranking 12941 National Ranking 370

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Apoptosis
  • Immune system

James E. Vince focuses on Programmed cell death, Cell biology, Inflammasome, Necroptosis and Caspase 8. Pyroptosis is the focus of his Programmed cell death research. His Cell biology study incorporates themes from Inhibitor of apoptosis, Macrophage and Virulence.

His Inflammasome study is mostly concerned with Caspase 1 and AIM2. The various areas that James E. Vince examines in his Necroptosis study include Inflammation and Signal transducing adaptor protein. In his research, Systemic inflammation, Receptor, Baculoviral IAP repeat-containing protein 3, Caspase and Ripoptosome is intimately related to Cancer research, which falls under the overarching field of Caspase 8.

His most cited work include:

  • IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis (879 citations)
  • Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction (531 citations)
  • RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. (356 citations)

What are the main themes of his work throughout his whole career to date?

Cell biology, Programmed cell death, Necroptosis, Inflammasome and Caspase 8 are his primary areas of study. His biological study spans a wide range of topics, including Inhibitor of apoptosis, Innate immune system and Caspase 1. His Programmed cell death research is multidisciplinary, relying on both Tumor necrosis factor alpha and Effector.

His work on RIPK1 as part of general Necroptosis study is frequently connected to Lytic cycle, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Inflammasome research incorporates elements of Oxidative stress, Secretion and Mitochondrion. In Caspase 8, James E. Vince works on issues like Molecular biology, which are connected to Cycloheximide, Protein family, Bcl-2-associated X protein and Myeloid cells.

He most often published in these fields:

  • Cell biology (112.90%)
  • Programmed cell death (102.42%)
  • Necroptosis (65.32%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cell biology (112.90%)
  • Programmed cell death (102.42%)
  • Inflammasome (59.68%)

In recent papers he was focusing on the following fields of study:

James E. Vince mostly deals with Cell biology, Programmed cell death, Inflammasome, Necroptosis and Pyroptosis. His work carried out in the field of Cell biology brings together such families of science as Inhibitor of apoptosis, Caspase 1, Bcl-2 Homologous Antagonist-Killer Protein and Intrinsic apoptosis. His Programmed cell death study is focused on Apoptosis in general.

His Inflammasome study combines topics from a wide range of disciplines, such as Oxidative stress, Cell type, Cytokine and Effector. His research integrates issues of Signal transduction and Intracellular in his study of Necroptosis. The study incorporates disciplines such as Cancer research and Interferon type I in addition to Pyroptosis.

Between 2017 and 2021, his most popular works were:

  • Pyroptosis versus necroptosis: similarities, differences, and crosstalk (126 citations)
  • Pyroptosis versus necroptosis: similarities, differences, and crosstalk (126 citations)
  • Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications. (73 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Apoptosis
  • Immune system

James E. Vince mainly investigates Programmed cell death, Inflammasome, Cell biology, Necroptosis and Inflammation. His research on Programmed cell death focuses in particular on Pyroptosis. He has included themes like Cancer research and Priming in his Pyroptosis study.

His Inflammasome study combines topics in areas such as Secretion, Insulin resistance, Innate immune system, Cell type and Type 2 Diabetes Mellitus. His Cell biology research is multidisciplinary, incorporating elements of Inhibitor of apoptosis, XIAP, Caspase, Caspase 8 and Caspase 1. His work deals with themes such as Diabetes mellitus, Oxidative stress, Disease and Bioinformatics, which intersect with Inflammation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

James E. Vince;W. Wei-Lynn Wong;Nufail Khan;Rebecca Feltham.
Cell (2007)

1098 Citations

Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction

Tobias L. Haas;Christoph H. Emmerich;Christoph H. Emmerich;Bjã¶rn Gerlach;Bjã¶rn Gerlach;Anna C. Schmukle.
Molecular Cell (2009)

662 Citations

Inhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation

James E. Vince;W. Wei Lynn Wong;W. Wei Lynn Wong;Ian Gentle;Kate E. Lawlor;Kate E. Lawlor.
Immunity (2012)

438 Citations

RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.

James A Rickard;James A Rickard;Joanne A O'Donnell;Joanne A O'Donnell;Joseph M Evans;Joseph M Evans;Najoua Lalaoui;Najoua Lalaoui.
Cell (2014)

422 Citations

RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL

Kate E. Lawlor;Nufail Khan;Alison Mildenhall;Motti Gerlic.
Nature Communications (2015)

363 Citations

AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC

V Sagulenko;S J Thygesen;D P Sester;A Idris.
Cell Death & Differentiation (2013)

340 Citations

The NLRP3 inflammasome in health and disease: the good, the bad and the ugly

P Menu;J E Vince.
Clinical and Experimental Immunology (2011)

328 Citations

TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα

James E. Vince;Diep Chau;Bernard Callus;W. Wei-Lynn Wong.
Journal of Cell Biology (2008)

251 Citations

TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis

James E. Vince;Delara Pantaki;Rebecca Feltham;Peter D. Mace.
Journal of Biological Chemistry (2009)

234 Citations

Pyroptosis versus necroptosis: similarities, differences, and crosstalk

Daniel Frank;Daniel Frank;James E. Vince;James E. Vince.
Cell Death & Differentiation (2019)

215 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing James E. Vince

John Silke

John Silke

Walter and Eliza Hall Institute of Medical Research

Publications: 156

Simone Fulda

Simone Fulda

Goethe University Frankfurt

Publications: 94

James M. Murphy

James M. Murphy

Walter and Eliza Hall Institute of Medical Research

Publications: 92

Peter Vandenabeele

Peter Vandenabeele

Ghent University

Publications: 64

Henning Walczak

Henning Walczak

University College London

Publications: 56

Domagoj Vucic

Domagoj Vucic

Genentech

Publications: 51

Andreas Strasser

Andreas Strasser

Walter and Eliza Hall Institute of Medical Research

Publications: 45

Thirumala-Devi Kanneganti

Thirumala-Devi Kanneganti

St. Jude Children's Research Hospital

Publications: 42

Douglas R. Green

Douglas R. Green

St. Jude Children's Research Hospital

Publications: 41

David L. Vaux

David L. Vaux

Walter and Eliza Hall Institute of Medical Research

Publications: 38

Francis Ka-Ming Chan

Francis Ka-Ming Chan

Duke University

Publications: 36

Robert G. Korneluk

Robert G. Korneluk

University of Ottawa

Publications: 34

Peter E. Czabotar

Peter E. Czabotar

Walter and Eliza Hall Institute of Medical Research

Publications: 34

Manolis Pasparakis

Manolis Pasparakis

University of Cologne

Publications: 33

Kazuhiro Iwai

Kazuhiro Iwai

Kyoto University

Publications: 32

John Bertin

John Bertin

GlaxoSmithKline (United Kingdom)

Publications: 30

Trending Scientists

James Colliander

James Colliander

University of British Columbia

Hong Xia

Hong Xia

Jilin University

Zhongchang Wang

Zhongchang Wang

Tohoku University

Per Alström

Per Alström

Uppsala University

Chaolun Allen Chen

Chaolun Allen Chen

Academia Sinica

Bjarne O. Braastad

Bjarne O. Braastad

Norwegian University of Life Sciences

Jennifer R. Wortman

Jennifer R. Wortman

Broad Institute

Jim Cole

Jim Cole

University of Canterbury

Frédéric Herman

Frédéric Herman

University of Lausanne

Stephanie Pincetl

Stephanie Pincetl

University of California, Los Angeles

Mark R. Newton

Mark R. Newton

University of Melbourne

Sanford L. Palay

Sanford L. Palay

Harvard University

Youhai H. Chen

Youhai H. Chen

University of Pennsylvania

Mario Talajic

Mario Talajic

Montreal Heart Institute

David R. Gandara

David R. Gandara

University of California, Davis

C. Seth Landefeld

C. Seth Landefeld

University of Alabama at Birmingham

Something went wrong. Please try again later.